National Institutes of Health's Therapeutics Portfolio

Resvita Bio develops and manufactures engineered probiotics for use in treatment if skin related diseases including cancer.

Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.

Strykagen manufactures transforming diagnostics and therapeutics for life-threatening rare muscle diseases.

Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight.

Greenstone Biosciences is a drug discovery platform that accelerates the development of effective therapies for patients.

Nexilico is an early-stage startup developing predictive computational platforms for gut microbiome precision medicine.

This company is a Boston-based biopharmaceutical company developing immune-based approaches.

Opsin Biotherapeutics develops a pipeline of opsin-based gene therapies for pain management

Atom Bioworks is a developer of a pattern-recognition enabled sensing and therapeutics platform designed to help in medical.

Advent Therapeutics is focused on providing therapies for micro-orphan applications.

Caeregen Therapeutics is committed to finding and creating innovative medicinal solutions.

Orlance provides more effective therapeutic and preventive vaccines for a wide spectrum of viral targets.

Lamassu Pharma is a biotech startup that solves the critical unmet medical need for severe acute pancreatitis.

Metaclipse Therapeutics Corporation is a preclinical-stage biotechnology company

Neuroene Therapeutics offers novel small molecule mitochondrial therapeutics for epilepsy, Parkinson's Disease, and mitochondrial disease.

iQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.

Hillhurst develops technologies enabling the therapeutic use of low-dose carbon monoxide.

Hepatx is developing regenerative medicine solutions.

Sparian Biosciences is a biopharmaceutical company.

TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.

AcuraStem harnesses human, patient-specific in vitro cell models and assays to develop cures and improve diagnoses in disorders of the CNS.

Lucid Diagnostics develops a non-invasive, office based diagnostic test for biomarkers to esophageal cancer.

Oxalo Therapeutics creates drugs to treat rare kidney diseases and prevent recurring kidney stones.

InVivo Biosystems specializes in genome editing and preclinical research for neurological, metabolic, and rare monogenic diseases.

PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.

AivoCode is an emerging biotech focused on critical and highly prevalent diseases affecting the central nervous system

Myosin Therapeutics is a privately-held biopharmaceutical company developing novel medications for CNS-based disorders.

MAIA Biotechnology is a clinical-stage biopharmaceutical company developing cancer therapies that target telomeres through immunotherapy.

Perspective Therapeutics focuses on advancing cancer treatments employing radiation, radiopharmaceuticals, and imaging technology.

Syntis Bio operates as a late-stage preclinical company that develops oral therapies for obesity, diabetes, and rare diseases.

Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.

Trefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases.

Zenflow is a medical company that gives new hope to men suffering from BPH symptoms.

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

Kinoxis Therapeutics is a biotechnology company that develops a range of novel therapeutic compounds.

Spinogenix is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases.

Envisagenics reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions.

SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.

Integrated BioTherapeutics focuses on the discovery of novel vaccines and therapeutics for emerging infectious diseases.

Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.

Amplo Biotechnology is to develop multiple, potentially curative, Adeno-Associated Viral (AAV) therapies for the neuromuscular junction.

CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity.

Prapela is a noninvasive stimuation therapy that improves breathing and oxygenation in newborns.

ProLynx is a biotechnology company that develops proprietary drug-delivery technologies to extend the half-life of therapeutic molecules.

4E Therapeutics is a neuroscience company that develops therapies for chronic neuropathic pain.

Brixton Biosciences is a clinical-stage life sciences company that develops therapies for chronic and acute pain.

Avexegen Therapeutics is a biotechnology company developing therapies for gastrointestinal disorders.

Scioto is a developer of Activated Bacterial Therapeutics platform.

Haima Therapeutics is a pre-clinical stage biotechnology company.

SciBac is a developer of biotherapeutics intended to treat antibiotic diseases.

CerSci Therapeutics is poised to deliver a new generation of non-opioid medicines to treat acute and chronic pain.

A live image of radiation therapy

Commence Bio is a therapeutics company developing methods to improve the anti-inflammatory properties of stem cells.